Design Therapeutics, Inc. logo DSGN - Design Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 4
HOLD 3
SELL 0
STRONG
SELL 0
| PRICE TARGET: $20.50 DETAILS
HIGH: $21.00
LOW: $20.00
MEDIAN: $20.50
CONSENSUS: $20.50
UPSIDE: 34.96%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 17.14
Quick Ratio 17.14
Solvency Ratio -5.049
Cash Ratio 1.29

Valuation Ratios

Ratio Value
Price/Earnings
-7.69
Peers avg: 25.5
PEG Ratio -0.20
Forward PEG -0.20
Price/Book 2.53
Price/Sales 0.00
Price/FCF -9.86
Price/Op Cash Flow -9.89

Debt Ratios

Ratio Value
Debt/Assets 0.0068
Debt/Equity 0.0072
Debt/Capital 0.0072
Long-Term Debt/Capital 0.0030
Financial Leverage 1.06

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -4.164
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.4%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.00
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage -35.41
Capital Expenditure Coverage -281.65
Dividend + Capital Expenditure Coverage -281.65

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -1.217
Debt/Share 0.0268
Cash/Share 3.83
Book Value/Share 3.71
Tangible BV/Share 3.71
Equity/Share 3.71
Operating Cash Flow/Share -0.948
Capital Expenditure/Share 0.003
FCF/Share -0.952

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.878
Price/Fair Value 2.53
Debt/Market Cap 0.0012
Effective Tax Rate 0.0%
Enterprise Value Multiple -7.55